Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.052.041 |
Chemical and physical data | |
Formula | C15H13FO2 |
Molar mass | 244.265 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Tarenflurbil,[1] Flurizan or R-flurbiprofen, is a single enantiomer of the racemate NSAID flurbiprofen. For several years, research and trials for the drug were conducted by Myriad Genetics, to investigate its potential as a treatment for Alzheimer's disease; that investigation concluded in June 2008 when the company announced it would discontinue development of the compound.[2]